Evidence map›Paper›PMID 41380666›Full record

ArticleCell host & microbe2025

Segregating pneumonia into pneumotypes.

Anne E D'Armond, Jay K Kolls

Abstract read
In one paragraph

Article in Cell host & microbe, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Anne E D'ArmondDepartments of Medicine and Pediatrics, Center for Translational Research in Infection and Inflammation, Tulane University School of Medicine, New Orleans, LA 70112, USA.
Jay K KollsDepartments of Medicine and Pediatrics, Center for Translational Research in Infection and Inflammation, Tulane University School of Medicine, New Orleans, LA 70112, USA. Electronic address: jkolls1@tulane.edu.

Funding

CD4+ T cell Immunity in the Respiratory TractR35HL177381 · NHLBI · TULANE UNIVERSITY OF LOUISIANA · PI JAY K KOLLS · 2025 to 2026
$2.1M
NHLBI NIH HHS R35 HL177381
6 · The paper itself

Abstract

In this issue of Cell Host & Microbe, Sumner et al. utilize a multi-omics approach to delineate various "pneumotypes," or distinct microbial states, in the lungs of patients with pneumonia. These pneumotypes have potential predictive value for clinical outcomes and therapeutic success.

Indexed as

LungPneumoniaPneumonia, PneumococcalStreptococcus pneumoniaeHumans

Identifiers

PMID41380666
PMCPMC13051273

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.